Citius Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2023
Amendment No. 2 to Amended and Restated License, Development and Commercialization Agreement, dated as of August 31, 2021, between Eisai, Ltd. and Dr. Reddys Laboratories S.A
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amendment to Amended and Restated License, Development and Commercialization Agreement, dated as of August 9, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amended and Restated License, Development and Commercialization Agreement, dated as of February 26, 2018, between Eisai, Ltd. and Dr. Reddys Laboratories S.A
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
License Agreement, dated October 6, 2020, between NoveCite, Inc. and Novellus Therapeutics, Limited
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2019
First Amendment, dated October 15, 2015, to Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron...
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2019
Patent and Technology License Agreement, dated January 2, 2019, between the Board of Regents of the University of Texas System on behalf of the University of Texas M. D. Anderson...
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
TX
2019
Second Amendment to the Patent and Technology License Agreement dated March 20, 2017 between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
2017
EXCLUSIVE LICENSE AGREEMENT Prenzamax, LLC and Citius Pharmaceuticals, LLC 1 EXCLUSIVE LICENSE AGREEMENT
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015
EXCLUSIVE LICENSE AGREEMENT Prenzamax, LLC and Citius Pharmaceuticals, LLC 1 EXCLUSIVE LICENSE AGREEMENT
License Agreements
Citius Pharmaceuticals, Inc.
Pharmaceuticals
MA
2015